These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 30688231)
1. Peripheral nerve tumors in neurofibromatosis 1: An overview on management and indications for surgical treatment in our experience. Garozzo D Neurol India; 2019; 67(Supplement):S38-S44. PubMed ID: 30688231 [TBL] [Abstract][Full Text] [Related]
2. Association between benign and malignant peripheral nerve sheath tumors in NF1. Tucker T; Wolkenstein P; Revuz J; Zeller J; Friedman JM Neurology; 2005 Jul; 65(2):205-11. PubMed ID: 16043787 [TBL] [Abstract][Full Text] [Related]
3. Pediatric plexiform neurofibromas: impact on morbidity and mortality in neurofibromatosis type 1. Prada CE; Rangwala FA; Martin LJ; Lovell AM; Saal HM; Schorry EK; Hopkin RJ J Pediatr; 2012 Mar; 160(3):461-7. PubMed ID: 21996156 [TBL] [Abstract][Full Text] [Related]
4. Association of plexiform and diffuse neurofibromas with malignant peripheral nerve sheath tumor in NF I patients: a whole-body MRI assessment. Attia S; Guirguis M; Le LQ; Chhabra A Skeletal Radiol; 2024 Apr; 53(4):769-777. PubMed ID: 37903998 [TBL] [Abstract][Full Text] [Related]
5. Plexiform neurofibromas. Korf BR Am J Med Genet; 1999 Mar; 89(1):31-7. PubMed ID: 10469434 [TBL] [Abstract][Full Text] [Related]
6. Surgery for Peripheral Nerve Sheath Tumours of the Buttocks, Legs and Feet in 90 Patients With Neurofibromatosis Type 1. Friedrich RE; Tuzcu CT In Vivo; 2021; 35(2):889-905. PubMed ID: 33622881 [TBL] [Abstract][Full Text] [Related]
7. Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: Tritto V; Ferrari L; Esposito S; Zuccotti P; Bianchessi D; Natacci F; Saletti V; Eoli M; Riva P Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31694342 [TBL] [Abstract][Full Text] [Related]
8. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients. Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810 [TBL] [Abstract][Full Text] [Related]
9. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR. Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999 [TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. Salamon J; Mautner VF; Adam G; Derlin T Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104 [TBL] [Abstract][Full Text] [Related]
11. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1. Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009 [TBL] [Abstract][Full Text] [Related]
12. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Pemov A; Hansen NF; Sindiri S; Patidar R; Higham CS; Dombi E; Miettinen MM; Fetsch P; Brems H; Chandrasekharappa SC; Jones K; Zhu B; Wei JS; ; ; Mullikin JC; Wallace MR; Khan J; Legius E; Widemann BC; Stewart DR Neuro Oncol; 2019 Aug; 21(8):981-992. PubMed ID: 30722027 [TBL] [Abstract][Full Text] [Related]
13. Single-stage total endoscopic resection of a plexiform neurofibroma of the maxillary sinus in a child with type 1 neurofibromatosis. Hachem RN; Bared A; Zeitouni J; Younis RT Int J Pediatr Otorhinolaryngol; 2010 Apr; 74(4):426-9. PubMed ID: 20074816 [TBL] [Abstract][Full Text] [Related]
14. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up. Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584 [TBL] [Abstract][Full Text] [Related]
15. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis. Woodruff JM Am J Med Genet; 1999 Mar; 89(1):23-30. PubMed ID: 10469433 [TBL] [Abstract][Full Text] [Related]
17. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1. Friedrich RE; Keiner D; Hagel C Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1. Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051 [TBL] [Abstract][Full Text] [Related]
19. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Waggoner DJ; Towbin J; Gottesman G; Gutmann DH Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438 [TBL] [Abstract][Full Text] [Related]
20. A series of 397 peripheral neural sheath tumors: 30-year experience at Louisiana State University Health Sciences Center. Kim DH; Murovic JA; Tiel RL; Moes G; Kline DG J Neurosurg; 2005 Feb; 102(2):246-55. PubMed ID: 15739552 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]